NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free NTRB Stock Alerts $3.55 -0.10 (-2.74%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$3.54▼$3.8250-Day Range$2.30▼$5.0652-Week Range$1.53▼$5.93Volume10,282 shsAverage Volume45,324 shsMarket Capitalization$27.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Nutriband alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Nutriband Stock (NASDAQ:NTRB)Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More NTRB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NTRB Stock News HeadlinesApril 28, 2024 | americanbankingnews.comNutriband Inc. (NASDAQ:NTRB) Short Interest Up 35.3% in AprilApril 26, 2024 | americanbankingnews.comHead to Head Analysis: Nutriband (NASDAQ:NTRB) versus Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF)April 28, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 25, 2024 | finance.yahoo.comIBN Coverage Initiated for Nutriband Inc.April 24, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA SubmissionApril 24, 2024 | finance.yahoo.comNutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA SubmissionApril 21, 2024 | uk.investing.comNutriband closes funding for abuse-deterrent fentanyl patchApril 1, 2024 | finance.yahoo.comNutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New BalanceApril 28, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 28, 2024 | marketwatch.comNutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA SubmissionMarch 27, 2024 | benzinga.comGerald Goodman's Net WorthMarch 27, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal PatchMarch 27, 2024 | finance.yahoo.comNutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal PatchJanuary 29, 2024 | finance.yahoo.comNutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1stJanuary 26, 2024 | finanznachrichten.deNutriband Inc.: Nutriband CEO Publishes Letter to ShareholdersJanuary 26, 2024 | finance.yahoo.comNutriband CEO Publishes Letter to ShareholdersJanuary 5, 2024 | finance.yahoo.comNutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl PatchDecember 29, 2023 | morningstar.comNutriband Inc NTRBDecember 18, 2023 | investorplace.comNTRB Stock Earnings: Nutriband Reported Results for Q3 2023November 28, 2023 | finance.yahoo.comNutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and CoolingNovember 28, 2023 | finance.yahoo.comNutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and CoolingOctober 11, 2023 | finance.yahoo.comNutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting FirmSeptember 20, 2023 | finanznachrichten.deFinancialnewsmedia.com: Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the RiseSeptember 20, 2023 | finanznachrichten.deNutriband Inc.: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent TechnologySeptember 20, 2023 | finance.yahoo.comNutriband Unveils Groundbreaking Innovation in Transdermal MedicationsSeptember 20, 2023 | finance.yahoo.comNutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent TechnologySeptember 12, 2023 | finance.yahoo.comNutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023See More Headlines Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/13/2021Today4/28/2024Next Earnings (Estimated)5/01/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:NTRB CUSIPN/A CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.67) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,480,000.00 Net Margins-252.90% Pretax Margin-252.90% Return on Equity-73.13% Return on Assets-57.85% Debt Debt-to-Equity Ratio0.37 Current Ratio2.79 Quick Ratio2.54 Sales & Book Value Annual Sales$2.08 million Price / Sales13.36 Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book3.26Miscellaneous Outstanding Shares7,830,000Free Float4,453,000Market Cap$27.80 million OptionableNot Optionable Beta0.86 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Serguei Melnik (Age 50)Founder, President, Company Secretary & Executive Chairman of the Board Comp: $200kMr. Gareth Sheridan (Age 34)Founder, CEO & Director Comp: $200kMr. Gerald Goodman (Age 76)CFO & Chief Accounting Officer Comp: $160kDr. Alan Smith Ph.D. (Age 58)COO & President of 4P Therapeutics Comp: $179kMr. Patrick Ryan (Age 38)Chief Technical Officer Dr. Jeffrey Patrick Pharm.D. (Age 54)Chief Scientific Officer Mr. Tyler Overk (Age 40)President of Active Intelligence More ExecutivesKey CompetitorsConformisNASDAQ:CFMSReWalk RoboticsNASDAQ:LFWDMilestone ScientificNYSE:MLSSVicarious SurgicalNYSE:RBOTCollPlant BiotechnologiesNASDAQ:CLGNView All CompetitorsInstitutional OwnershipAlphaQ Advisors LLCSold 5,834 shares on 1/29/2024Ownership: 0.149%View All Institutional Transactions NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed in 2024? Nutriband's stock was trading at $2.32 at the start of the year. Since then, NTRB stock has increased by 53.0% and is now trading at $3.55. View the best growth stocks for 2024 here. Are investors shorting Nutriband? Nutriband saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 49,100 shares, an increase of 35.3% from the March 31st total of 36,300 shares. Based on an average daily trading volume, of 43,100 shares, the days-to-cover ratio is presently 1.1 days. Currently, 1.3% of the company's shares are sold short. View Nutriband's Short Interest. When is Nutriband's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our NTRB earnings forecast. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) released its earnings results on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.11. The company earned $0.28 million during the quarter, compared to analyst estimates of $0.50 million. Nutriband had a negative net margin of 252.90% and a negative trailing twelve-month return on equity of 73.13%. When did Nutriband's stock split? Shares of Nutriband split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were distributed to shareholders after the closing bell on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NTRB) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
